Li Q, Ma H, Zheng R, Cai L, et al. Durvalumab combined with chemotherapy and Stereotactic Ablative Body Radiotherapy (SABR) in patients with oligometastatic non-small cell lung cancer: a multi-center phase 2 study. Int J Radiat Oncol Biol Phys 2025 Sep 24:S0360-3016(25)06304.
PMID: 41005623